These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 20031749)

  • 1. Stent thrombosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry.
    Lagerqvist B; Carlsson J; Fröbert O; Lindbäck J; Scherstén F; Stenestrand U; James SK;
    Circ Cardiovasc Interv; 2009 Oct; 2(5):401-8. PubMed ID: 20031749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden.
    James SK; Stenestrand U; Lindbäck J; Carlsson J; Scherstén F; Nilsson T; Wallentin L; Lagerqvist B;
    N Engl J Med; 2009 May; 360(19):1933-45. PubMed ID: 19420363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction.
    Jensen LO; Maeng M; Thayssen P; Kaltoft A; Tilsted HH; Bøttcher M; Lassen JF; Hansen KN; Krusell LR; Rasmussen K; Pedersen KE; Pedersen L; Paaske Johnsen S; Sørensen HT; Thuesen L
    Circ Cardiovasc Interv; 2008 Dec; 1(3):176-84. PubMed ID: 20031676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry).
    Kaltoft A; Jensen LO; Maeng M; Tilsted HH; Thayssen P; Bøttcher M; Lassen JF; Krusell LR; Rasmussen K; Hansen KN; Pedersen L; Johnsen SP; Sørensen HT; Thuesen L
    J Am Coll Cardiol; 2009 Feb; 53(8):658-64. PubMed ID: 19232897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.
    Lagerqvist B; James SK; Stenestrand U; Lindbäck J; Nilsson T; Wallentin L;
    N Engl J Med; 2007 Mar; 356(10):1009-19. PubMed ID: 17296822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases.
    van Werkum JW; Heestermans AA; de Korte FI; Kelder JC; Suttorp MJ; Rensing BJ; Zwart B; Brueren BR; Koolen JJ; Dambrink JH; van't Hof AW; Verheugt FW; ten Berg JM
    Circulation; 2009 Feb; 119(6):828-34. PubMed ID: 19188507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry).
    Yan BP; Duffy SJ; Clark DJ; Lefkovits J; Warren R; Gurvitch R; Lew R; Sebastian M; Brennan A; Andrianopoulos N; Reid CM; Ajani AE;
    Am J Cardiol; 2008 Jun; 101(12):1716-22. PubMed ID: 18549846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors and implications of stent thrombosis in non-ST-segment elevation acute coronary syndromes: the ACUITY Trial.
    Palmerini T; Dangas G; Mehran R; Caixeta A; Généreux P; Fahy MP; Xu K; Cristea E; Lansky AJ; Stone GW
    Circ Cardiovasc Interv; 2011 Dec; 4(6):577-84. PubMed ID: 22028471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions.
    Jensen LO; Maeng M; Kaltoft A; Thayssen P; Hansen HH; Bottcher M; Lassen JF; Krussel LR; Rasmussen K; Hansen KN; Pedersen L; Johnsen SP; Soerensen HT; Thuesen L
    J Am Coll Cardiol; 2007 Jul; 50(5):463-70. PubMed ID: 17662400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Sarno G; Lagerqvist B; Fröbert O; Nilsson J; Olivecrona G; Omerovic E; Saleh N; Venetzanos D; James S
    Eur Heart J; 2012 Mar; 33(5):606-13. PubMed ID: 22232428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos).
    de la Torre-Hernández JM; Alfonso F; Hernández F; Elizaga J; Sanmartin M; Pinar E; Lozano I; Vazquez JM; Botas J; Perez de Prado A; Hernández JM; Sanchis J; Nodar JM; Gomez-Jaume A; Larman M; Diarte JA; Rodríguez-Collado J; Rumoroso JR; Lopez-Minguez JR; Mauri J;
    J Am Coll Cardiol; 2008 Mar; 51(10):986-90. PubMed ID: 18325436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.
    van Werkum JW; Heestermans AA; Zomer AC; Kelder JC; Suttorp MJ; Rensing BJ; Koolen JJ; Brueren BR; Dambrink JH; Hautvast RW; Verheugt FW; ten Berg JM
    J Am Coll Cardiol; 2009 Apr; 53(16):1399-409. PubMed ID: 19371823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.
    Ortolani P; Balducelli M; Marzaroli P; Piovaccari G; Menozzi A; Guiducci V; Sangiorgio P; Tarantino F; Geraci G; Castriota F; Tondi S; Saia F; Cooke RM; Guastaroba P; Grilli R; Marzocchi A; Maresta A
    Circulation; 2008 Feb; 117(7):923-30. PubMed ID: 18250265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry.
    Goswami NJ; Gaffigan M; Berrio G; Plessa AL; Pfeiffer AM; Markwell SJ; Mishkel GJ
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):93-100. PubMed ID: 19787803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
    Marzocchi A; Saia F; Piovaccari G; Manari A; Aurier E; Benassi A; Cremonesi A; Percoco G; Varani E; Magnavacchi P; Guastaroba P; Grilli R; Maresta A
    Circulation; 2007 Jun; 115(25):3181-8. PubMed ID: 17562952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between off-label use of drug-eluting stents and subsequent stent thrombosis: a case-control analysis.
    Rabinovitz A; Bier DM; Wagman GM; Charlap E; Nazari R; Ghitelman J; Celaj S; Skeif B; Menegus M; Srinivas VS
    J Invasive Cardiol; 2010 Jan; 22(1):15-9. PubMed ID: 20048393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term clinical outcomes and stent thrombosis of sirolimus-eluting versus bare metal stents in patients with end-stage renal disease: results of Korean multicenter angioplasty team (KOMATE) Registry.
    Kim BK; Oh S; Jeon DW; Yang JY; Kim JS; Park S; Choi D; Jang Y; Hong BK; Kwon HM; Lee SW; Goh CW; Kwon K; Ryu SK;
    J Interv Cardiol; 2009 Oct; 22(5):411-9. PubMed ID: 19702679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.